DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,623 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $7,118,000 | -73.9% | 32,045 | -74.7% | 0.74% | +155.9% |
| Q3 2020 | $27,288,000 | -29.6% | 126,730 | -52.8% | 0.29% | +28.0% |
| Q3 2019 | $38,778,000 | -24.8% | 268,502 | -25.6% | 0.22% | -16.0% |
| Q2 2019 | $51,578,000 | +99.6% | 360,885 | +84.4% | 0.27% | +101.5% |
| Q1 2019 | $25,844,000 | +12.0% | 195,760 | -12.6% | 0.13% | +2.3% |
| Q4 2018 | $23,085,000 | -38.5% | 223,865 | -35.2% | 0.13% | -26.6% |
| Q3 2018 | $37,552,000 | +89.9% | 345,591 | +72.5% | 0.18% | +94.5% |
| Q2 2018 | $19,771,000 | +565.5% | 200,356 | +560.4% | 0.09% | +550.0% |
| Q1 2018 | $2,971,000 | -20.6% | 30,340 | -24.7% | 0.01% | -12.5% |
| Q4 2017 | $3,740,000 | +38.8% | 40,292 | +28.3% | 0.02% | +33.3% |
| Q3 2017 | $2,694,000 | -4.1% | 31,405 | -5.7% | 0.01% | 0.0% |
| Q2 2017 | $2,810,000 | +13.1% | 33,301 | +14.7% | 0.01% | +20.0% |
| Q1 2017 | $2,484,000 | +9.7% | 29,040 | -0.2% | 0.01% | +11.1% |
| Q4 2016 | $2,265,000 | -4.1% | 29,104 | -3.5% | 0.01% | -10.0% |
| Q3 2016 | $2,363,000 | – | 30,149 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |